Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology

Thrombosis Clinical Trials


A listing of Thrombosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : University of Alabama at Birmingham

Clarification of Optimal Anticoagulation Through Genetics

Dothan :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Montgomery :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Arizona

Glendale : Arrowhead Hospital/Phoenix Heart, PLLC

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Phoenix : Phoenix Children's Hospital

Evaluation of the Duration of Therapy for Thrombosis in Children

Arkansas

Little Rock : Arkansas Children'S Hospital

Pediatric Catheter-related Thrombosis Imaging Study

California

Los Angeles :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Los Angeles :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Orange : St. Joseph Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

San Diego : Rady Children's Hospital UCSD

Evaluation of the Duration of Therapy for Thrombosis in Children

San Francisco : University of California San Francisco

Clarification of Optimal Anticoagulation Through Genetics

View More »

Santa Clara : Abbott Vascular

EXCEL Clinical Trial

Stanford : Stanford University Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Colorado

Aurora : University Of Colorado Denver

Pediatric Catheter-related Thrombosis Imaging Study

Denver : University of Colorado School of Medicine

Evaluation of the Duration of Therapy for Thrombosis in Children

Connecticut

Danbury : Danbury Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Norwich : Eastern Connecticut Hematology and Oncology Associates

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Delaware

Newark : Christiana Care Health Systems

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

District of Columbia

Washington : George Washington University, Children's National Medical Center

Evaluation of the Duration of Therapy for Thrombosis in Children

Florida

Clearwater :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Ft. Myers :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Gainesville : University of Florida

Clarification of Optimal Anticoagulation Through Genetics

Orlando : Florida Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Sarasota :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

View More »

St. Petersburg : All Children's Hospital

Evaluation of the Duration of Therapy for Thrombosis in Children

Tampa : Pepin Heart Hospital / University Community Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Georgia

Atlanta :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Augusta : Georgia Health Sciences University

Clarification of Optimal Anticoagulation Through Genetics

Jonesboro :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Illinois

Chicago : University of Illinois at Chicago

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Chicago :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Hinsdale : Adventist Midwest Health

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Springfield : Southern Illinois University

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Winfield : Central DuPage Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Indiana

Indianapolis : CorVasc

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Lafayette :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Iowa

Iowa City : University of Iowa Carver's College of Medicine

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Kentucky

Florence : St. Elizabeth Healthcare of Northern Kentucky

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Paducah :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Louisiana

Covington :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

New Orleans : Tulane University Health Science Center

Clarification of Optimal Anticoagulation Through Genetics

Maine

Portland : Maine Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Maryland

Baltimore : Johns Hopkins Bayview Medical Center

A Pilot Study Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients

Baltimore :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Baltimore : University of Maryland School of Medicine

Clarification of Optimal Anticoagulation Through Genetics

Randallstown :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Massachusetts

Boston : Massachusetts General Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Michigan

Ann Arbor : Ann Arbor Veteran's Administration Health System

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Ann Arbor : University of Michigan Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Detroit : Henry Ford Health System

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Detroit : Henry Ford Hospital

Clarification of Optimal Anticoagulation Through Genetics

Detroit : Children's Hospital of Michigan, Wayne State University

Evaluation of the Duration of Therapy for Thrombosis in Children

View More »

East Lansing : Michigan State University

Evaluation of the Duration of Therapy for Thrombosis in Children

Minnesota

Rochester : Mayo Clinic

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Rochester : Mayo Clinic College of Medicine

Clarification of Optimal Anticoagulation Through Genetics

Missouri

Kansas City : Children'S Mercy Hospital And Clinics

Pediatric Catheter-related Thrombosis Imaging Study

Saint Louis :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

St. Louis : Washington University School of Medicine

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

St. Louis : Washington University School of Medicine

Clarification of Optimal Anticoagulation Through Genetics

Montana

Butte :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Nebraska

Lincoln : Saint Elizabeth Regional Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

New Jersey

Teaneck : Holy Name Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

New Mexico

Albuquerque : University of New Mexico

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

New York

Bronx : Montefiore Medical Center

Clarification of Optimal Anticoagulation Through Genetics

Buffalo : Kaleida Health System

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

New York : Cornell Weill Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

New York : Mount Sinai School of Medicine

Clarification of Optimal Anticoagulation Through Genetics

New York : Weill Medical College of Cornell University

Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction

View More »

New York :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Rochester :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Staten Island : Staten Island University Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Valhalla :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

North Carolina

Raleigh : Rex Healthcare

AMPLIFY- A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism

View More »

Chapel Hill : University of North Carolina at Chapel Hill

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Durham :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Durham : Duke University

Clarification of Optimal Anticoagulation Through Genetics

Durham : Duke University

Evaluation of the Duration of Therapy for Thrombosis in Children

Durham :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Winston Salem : Wake Forest University Baptist Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Winston Salem :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Winston-Salem : Forsyth Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

North Dakota

Bismarck : Legacy Pharma Research

Prevention of venous thromboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy

Ohio

Cincinatti : Good Samaritan Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Cincinnati : Cincinnati Children'S Hospital Medical Center

Pediatric Catheter-related Thrombosis Imaging Study

Cleveland : Cleveland Clinic

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Cleveland : Cleveland Clinic

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Colombus : Univeristy Medical Center

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

View More »

Columbus : Riverside Methodist Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Columbus : Nationwide Children's Hospital

Evaluation of the Duration of Therapy for Thrombosis in Children

Columbus :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Toledo : Jobst Vascular Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Oklahoma

Oklahoma City : University of Oklahoma Health Sciences Center, Department of Medicine, PO Box 26901

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

Oregon

Portland : Oregon Health & Science University

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Pennsylvania

Bethlehem : St. Luke's Hospital and Health Network

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Camp Hill :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Ephrata :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Philadelphia : Temple University Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Philadelphia : Albert Einstein Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

View More »

Philadelphia : Hospital of the University of Pennsylvania

Clarification of Optimal Anticoagulation Through Genetics

Philadelphia : The Children'S Hospital Of Philadelphia

Pediatric Catheter-related Thrombosis Imaging Study

Pittsburgh : University of Pittsburgh Medical Center Presbyterian Shadyside

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Pittsburgh : Allegheny General Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Pittsburgh : The Western Pennsylvania Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Pittsburgh : Children'S Hopsital Of Pittsburgh Of Upmc

Pediatric Catheter-related Thrombosis Imaging Study

Pittsburgh :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Sellersville :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

West Reading : The Reading Hospital and Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Rhode Island

Providence : Rhode Island Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

South Carolina

Charleston : Medical University of South Carolina

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Charleston : Medical Center of South Carolina

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Tennessee

Nashville : Vanderbilt University

Clarification of Optimal Anticoagulation Through Genetics

Nashville : Vanderbilt University

Evaluation of the Duration of Therapy for Thrombosis in Children

Texas

Dallas : University of Texas Southwestern

Evaluation of the Duration of Therapy for Thrombosis in Children

Fort Worth : Cook Children's Hospital

Evaluation of the Duration of Therapy for Thrombosis in Children

Galveston : University of Texas Medical Branch

Clarification of Optimal Anticoagulation Through Genetics

Houston : Texas Children's Cancer Center, Baylor College of Medicine

Evaluation of the Duration of Therapy for Thrombosis in Children

Houston : Texas Children'S Hospital

Pediatric Catheter-related Thrombosis Imaging Study

View More »

Houston : Ut Health/Gulf States Hemophilia & Thrombophilia Ctr.

Pediatric Catheter-related Thrombosis Imaging Study

Utah

Murray : Intermountain Medical Center

Clarification of Optimal Anticoagulation Through Genetics

Salt Lake City : University of Utah

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Salt Lake City : University of Utah Health Care

Clarification of Optimal Anticoagulation Through Genetics

Salt Lake City :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Virginia

Charlottesville : University of Virginia Health System

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Fredericksburg :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Washington

Tacoma :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Wisconsin

Marshfield : Marshfield Clinical Research Foundation

Clarification of Optimal Anticoagulation Through Genetics

Milwaukee : Medical College of Wisconsin/Froedtert Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Wauwatosa : Medical College of Wisconsin, Blood Center of Wisconsin

Evaluation of the Duration of Therapy for Thrombosis in Children

Argentina

Buenos Aires : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Australia

Liverpool :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Melbourne :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Melbourne : Royal Melbourne hospital

The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.

Parkville :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Wooloongabba :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Austria

Graz :

Oral Rivaroxaban in Children With Venous Thrombosis

Graz :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Vienna : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Vienna :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

View More »

Wien :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Belgium

Antwerp :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Brussels : Erasme Hospital, Brussels

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Brussels :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Edegem : University Hospital Antwerp

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Genk : Ziekenhuis Oost Limburg, Campus St. Jan

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

View More »

Ghent : Drug Research Unit Ghent

A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

Leuven : Chirurgie UZ Leuven

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Leuven :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Namur :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Bulgaria

Sofia : Clinic of Vascular Surgery and Angiology

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Sofia : Tokuda Hospital Sofia

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Sophia :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Canada

Edmonton :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Edmonton : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Edmonton :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Hamilton :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Hamilton : St. Joseph's Healthcare Hamilton

The Risk of Venous Clotting in Patients After Renal Transplant

View More »

Hamilton : St Joseph's Healthcare Hamilton

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Montréal : Maisonneuve Rosemont Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Ottawa : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Toronto : St. Michael's Hospital

Atorvastatin for the Treatment of Retinal Vein Occlusion

Toronto : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Czech Republic

Ostrava - Vitkovice : Vascular Centre Vitkovicka Nemocnice

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Prague : IKEM, Kardiologicka klinika

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Prague : University Hospital Kralovske Vinobrady

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Prague : Cevni Chirurgie, Nemocnice Na Homolce

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Prague 2 : Institute of Hematology and Blood Transfusion, Coagulation Laboratory, U nemocnice 1

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

View More »

Usti nad Labem : Chirurgicka klinika IPVZ

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Denmark

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

France

Caen :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Dijon : University Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Grenoble : University Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Montelimar : Cabinet

Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome

View More »

Paris : Unite de Recherches Therapeutiques, Hopital Lariboisiere

Vitamin K2 Intervention in Patients With Vitamin K Antagonists

Germany

Aachen :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Baesweiler : Chriurgische Praxisklinik

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Berlin :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Berlin : DEutsches Rotes Kreuz Schwesternschaft Berlin Gemeinnütziges Krankenhaus GmbH

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Bonn : Universitätsklinikum Bonn, Radiologische Universitätsklinik

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

View More »

Bonn : Universitäts-Hautklinik Bonn

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Dortmund :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Dresden : Universitäts GefäßCentrum Uniklinikum Dresden

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Dresden : Universitätsklinikum Dresden

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Freiburg : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Freiburg : Hautarztpraxis

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Hannover : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Hannover :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Karlsbach : Akademie für Gefäßkrankheiten e.V.

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Köln :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Leipzig : Klinik für Innere Medizin I - Angiologie / Kardiologie

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Mainz :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Mannheim :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Mühldorf am Inn : Kardiologie Mühldorf am Inn

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Munchen :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

München : Gemeinschaftspraxis Mietaschk, Bilderling, Kaiser, Tato

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

India

Gujarat : Life Care Institute of Medical Sciences and Research

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Karnataka : Gokula Metropolis Clinical Research Centre, M. S. Ramaiah Hospital

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Israel

Haifa :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Jerusalem :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Petach Tikva :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Tel Hashomer :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Italy

Bologna : University Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Catania :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Foggia :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Genova :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Milan : IRCCS H San Raffaele

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

View More »

Milan :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Reggio Emilia :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Rome :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Torino :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Japan

Chuo-ku : St. Luke's International Hospital

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

Kashihara city : Nara Medical University, Department of Blood Transfusion Medicine, Shijyo-cho 840

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

Tsu : Mie University Hospital

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

Mexico

Col. Secc Xvi Tlalpan : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Monterrey : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Netherlands

Amsterdam : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Norway

Trondheim : Trondheim University St Olavs Hospital, Department of Hematology, PO Box 3250 Sluppen

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

Peru

Lima : Instituto Neuro Cardiovascular de las Americas

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Lima : Centro de Investigación y Atención Cardiovascular

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Lima : Hospital Nacional Edgardo Rebagliati Martins

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Lima : Hospital Nacional Guillermo Almenara Irigoyen-EsSalud

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Poland

Bytom : Wojewodzki Szpital Specjalistyczny nr 4 w Bytomiu

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Chrzanow : Malopolskie Centrum Sercowo-Naczyniowe PAKS American Heart of Poland Sp. z o.o

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Gdansk : Uniwersyleckie Centrum Kliniczne

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Poznan : Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Poznan : Zaklad Opieki Zdrowonej Ministerstwa Spraw Wewnetrznych i Administracji w Poznaniu

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

View More »

Szczecin : Samodzielny Publiczny Szpital Kliniczny Nr 2 PUM w Szczecinie

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Romania

Bucharest :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Bucuresti : Institutul de Urgenta pentru Boli Cardiovasculare "Prof.Dr.C.C.Iliescu"

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Cluj-Napoca : Institutul Inimii "Nicolae Stancioiu" Cluj-Napoca

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Iasi : Inst.de Boli Cardiovasculare "Prof.I.M.Georgescu" Iasi

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Targu Mures : Institutul de Boli Cardiovasculare si Transplant Mures

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Serbia

Beograd : Klinicki Centar Srbije

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Beograd : Institut za kardiovaskularne bolesti Dedinje

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Nis : Klinicki Centar Nis

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Novi Sad : Klinicki Centar Vojvodine

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Slovakia

Bratislava : Oddelenie diagnostickej a intervencnej radiologie, The National Institute of Cardiovascular Diseases

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Kosice : The Eastern Slovak Institute of Cardiovascular Diseases

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Spain

Alcorcon : Fundacion Hospital Alcorcon

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Alicante : University Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Badalona :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Sevilla :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

View More »

Soria : General Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Valencia :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Sweden

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Stockholm : Karolinska University Hospital

Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture

Switzerland

Bern : University Clinic of Hematology and Central Hematology Laboratory, Bern University Hospital and the University of Bern, Inselspital

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

Bern :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Tunisia

Tunis : Hospital Charle Nicolle

Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin

United Kingdom

Glasgow : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Liverpool :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)

London : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

London :

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)